Samith T. Kochuparambil

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Phase 1/2a, open‐label, multicenter study of <scp>RM</scp>‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma

David M. Cognetti, Jennifer M. Johnson, Joseph Curry et al. · Head & Neck · 2021 · 157 citations · Full text

Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma

Raffit Hassan, Anish Thomas, John Nemunaitis et al. · JAMA Oncology · 2019 · 149 citations · Full text

Anticancer Efficacy of Simvastatin on Prostate Cancer Cells and Tumor Xenografts Is Associated with Inhibition of Akt and Reduced Prostate-Specific Antigen Expression

Samith T. Kochuparambil, Belal Al‐Husein, Anna Goc et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 133 citations

Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis

Anna Goc, Samith T. Kochuparambil, Belal Al‐Husein et al. · BMC Cancer · 2012 · 79 citations · Full text